XML 15 R4.htm IDEA: XBRL DOCUMENT v3.21.2
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
 3 Months Ended 9 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Sep. 30, 2021
Sep. 30, 2020
Income Statement [Abstract]        
Revenue, net $ 3,706,436 $ 1,634,669 $ 10,582,470 $ 5,127,018
Cost of revenue 2,959,264 1,108,758 8,208,368 3,869,758
Gross profit 747,172 525,911 2,374,102 1,257,260
Operating expenses:        
Advertising and marketing expenses 224,393 89,695 569,580 333,669
Product development costs 98,623 84,433 322,807 304,229
Selling, general and administrative expenses 866,699 634,447 2,493,930 2,453,976
Total operating expenses 1,189,715 808,575 3,386,317 3,091,874
Operating loss (442,543) (282,664) (1,012,215) (1,834,614)
Other income (expense):        
Other income (expense), net 35,934 13,621 79,452 29,018
Interest expense (1,296) (1,396) (3,268) (16,673)
Total other income (expense) 34,638 12,225 76,184 12,345
Loss before provision for income taxes (407,905) (270,439) (936,031) (1,822,269)
Income taxes
Net loss (407,905) (270,439) (936,031) (1,822,269)
Convertible Preferred Series B Stock Redemption Value Adjustment (2,262,847) (2,262,847)
Convertible Preferred Series B Stock Dividends (1,447) (1,447)
Net Loss Available to Common Shareholders $ (2,672,199) $ (270,439) $ (3,200,325) $ (1,822,269)
Loss per common share – basic and dilutive $ (0.01) $ (0.00) $ (0.01) $ (0.01)
Weighted average number of common shares outstanding, basic and dilutive 237,526,638 236,526,638 237,171,327 234,711,893